在癌症治疗的战场上,疫苗一直被寄予厚望,它就像一位英勇的战士,肩负着对抗癌症的重任。然而,现实却给这位战士设置了重重障碍。其中一个最棘手的问题就是,如何让癌症疫苗产生长期存活且功能强大的 T 细胞(一种在免疫系统中发挥关键作用的白细胞,能识别和攻击异常细胞),而且这些 T 细胞还得精准地针对肿瘤抗原。这就好比要训练出一批神枪手,不仅要百发百中,还得能长时间坚守岗位。
3 天
New Scientist on MSNCAR T-cells enable record-breaking 18-year nerve cancer remissionA person with neuroblastoma, which occurs when developing nerve cells in children turn cancerous, has remained tumour-free ...
Scientists engineered T cells to protect instead of kill, potentially enabling targeted treatments for autoimmune disease and ...
Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果